{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:42:47Z","timestamp":1785328967828,"version":"3.55.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1053\/j.jvca.2021.05.008","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T13:02:02Z","timestamp":1620738122000},"page":"952-961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Perioperative Implications of the 2020 American Heart Association Scientific Statement on Drug-Induced Arrhythmias\u2014A Focused Review"],"prefix":"10.1053","volume":"36","author":[{"given":"Matthew W.","family":"Vanneman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Madhok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam A.","family":"Dalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2021.05.008_bib0001","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","article-title":"Drug-induced arrhythmias: A scientific statement from the American Heart Association","volume":"142","author":"Tisdale","year":"2020","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.008_bib0002","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/bja\/aeh166","article-title":"Perioperative cardiac arrhythmias","volume":"93","author":"Thompson","year":"2004","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2021.05.008_bib0003","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.jacc.2012.08.1011","article-title":"Ventricular arrhythmia after cardiac surgery: incidence, predictors, and outcomes","volume":"60","author":"El-Chami","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0004","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41569-019-0166-5","article-title":"Postoperative atrial fibrillation: Mechanisms, manifestations and management","volume":"16","author":"Dobrev","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000542-199002000-00009","article-title":"Multicenter study of general anesthesia. II. Results","volume":"72","author":"Forrest","year":"1990","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2021.05.008_bib0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00000542-199201000-00002","article-title":"Multicenter study of general anesthesia. III. Predictors of severe perioperative adverse outcomes","volume":"76","author":"Forrest","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2021.05.008_bib0007","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/bja\/78.6.642","article-title":"Propofol and bradycardia: Causation, frequency and severity","volume":"78","author":"Tramer","year":"1997","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2021.05.008_bib0008","first-page":"S21","article-title":"Hemodynamic effects of propofol: Data from over 25,000 patients","volume":"77","author":"Hug","year":"1993","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.05.008_bib0009","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1503\/cjs.008117","article-title":"Propofol administration by endoscopists versus anesthesiologists in gastrointestinal endoscopy: A systematic review and meta-analysis of patient safety outcomes","volume":"61","author":"Daza","year":"2018","journal-title":"Can J Surg"},{"key":"10.1053\/j.jvca.2021.05.008_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00000542-200301000-00009","article-title":"Differential effects of propofol and sevoflurane on heart rate variability","volume":"98","author":"Kanaya","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2021.05.008_bib0011","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/j.1532-5415.2009.02488.x","article-title":"Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the Veterans Affairs New England healthcare system","volume":"57","author":"Hernandez","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1053\/j.jvca.2021.05.008_bib0012","article-title":"Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults","volume":"8","author":"Hristovska","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.jvca.2021.05.008_bib0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bja.2018.03.003","article-title":"Sugammadex-induced bradycardia and asystole: How great is the risk?","volume":"121","author":"Hunter","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2021.05.008_bib0014","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bja.2018.02.036","article-title":"Severe bradycardia and asystole after sugammadex","volume":"121","author":"Bhavani","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2021.05.008_bib0015","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1124\/jpet.107.132456","article-title":"Inhibition of the cardiac L-type calcium channel current by antidepressant drugs","volume":"324","author":"Zahradn\u00edk","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1053\/j.jvca.2021.05.008_bib0016","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004714-199910000-00004","article-title":"Cardiac safety of citalopram: Prospective trials and retrospective analyses","volume":"19","author":"Rasmussen","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1751-0759-2-12","article-title":"Effects of antidepressant treatment on heart rate variability in major depression: A quantitative review","volume":"2","author":"van Zyl","year":"2008","journal-title":"Biopsychosoc Med"},{"key":"10.1053\/j.jvca.2021.05.008_bib0018","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1345\/aph.1A136","article-title":"Citalopram-induced bradycardia and presyncope","volume":"35","author":"Isbister","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.jvca.2021.05.008_bib0019","first-page":"2","article-title":"Pharmacology of neuromuscular blocking drugs","volume":"4","author":"Appiah-Ankam","year":"2004","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"10.1053\/j.jvca.2021.05.008_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.33762\/bsurg.2017.132405","article-title":"Evaluation of the effect of second dose of succinylcholine on the pulse rate in non-atropinised patients under general anesthesia","volume":"23","author":"Abdul-Salam","year":"2017","journal-title":"Basrah J Surg"},{"key":"10.1053\/j.jvca.2021.05.008_bib0021","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-6576.1984.tb02049.x","article-title":"Bradycardia and cardiac asystole following a single injection of suxamethonium","volume":"28","author":"S\u00f8rensen","year":"1984","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1053\/j.jvca.2021.05.008_bib0022","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-4632.2004.02587.x","article-title":"Cardiovascular effects of corticosteroid pulse therapy: A prospective controlled study on pemphigus patients","volume":"44","author":"Jain","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0023","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MPH.0b013e31815dcfeb","article-title":"Glucocorticoid-associated bradycardia","volume":"30","author":"van der Gugten","year":"2008","journal-title":"J Pediatric Hematol Oncol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0024","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2011.07.018","article-title":"Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis","volume":"309","author":"Vasheghani-Farahani","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.jvca.2021.05.008_bib0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1715163515597451","article-title":"Corticosteroid-induced bradycardia","volume":"148","author":"Stroeder","year":"2015","journal-title":"Can Pharm J (Ott)"},{"key":"10.1053\/j.jvca.2021.05.008_bib0026","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-4632.2004.02587.x","article-title":"Cardiovascular effects of corticosteroid pulse therapy: A prospective controlled study on pemphigus patients","volume":"44","author":"Jain","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0027","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2011.07.018","article-title":"Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis","volume":"309","author":"Vasheghani-Farahani","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.jvca.2021.05.008_bib0028","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/bja\/83.2.302","article-title":"Magnesium: Physiology and pharmacology","volume":"83","author":"Fawcett","year":"1999","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2021.05.008_bib0029","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ams2.334","article-title":"The characteristics of patients with hypermagnesemia who underwent emergency hemodialysis","volume":"5","author":"Nishikawa","year":"2018","journal-title":"Acute Med Surg"},{"key":"10.1053\/j.jvca.2021.05.008_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-218260","article-title":"Near death by milk of magnesia","volume":"2017","author":"Alaini","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1053\/j.jvca.2021.05.008_bib0031","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jemermed.2011.09.004","article-title":"Hypermagnesemia in a constipated female","volume":"44","author":"Weng","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1053\/j.jvca.2021.05.008_bib0032","series-title":"Beta Blockers: StatPearls","author":"Farzam","year":"2020"},{"key":"10.1053\/j.jvca.2021.05.008_bib0033","article-title":"Perioperative beta-blockers for preventing surgery-related mortality and morbidity","volume":"3","author":"Blessberger","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.jvca.2021.05.008_bib0034","series-title":"Calcium Channel Blockers: StatPearls","author":"McKeever","year":"2020"},{"key":"10.1053\/j.jvca.2021.05.008_bib0035","first-page":"e382","volume":"140","author":"Kusumoto Fred","year":"2019","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.008_bib0036","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bcp.12763","article-title":"Calcium channel antagonist and beta-blocker overdose: Antidotes and adjunct therapies","volume":"81","author":"Graudins","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0037","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/15563650.2020.1752918","article-title":"Treatment for beta-blocker poisoning: A systematic review","volume":"58","author":"Rotella","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1053\/j.jvca.2021.05.008_bib0038","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.annemergmed.2013.03.018","article-title":"Critical care management ofverapamil and diltiazem overdose with a focus on vasopressors: A 25-year experience at a single center","volume":"62","author":"Levine","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1053\/j.jvca.2021.05.008_bib0039","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","article-title":"Aspirin in patients undergoing noncardiac surgery","volume":"370","author":"Devereaux","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2021.05.008_bib0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bja.2019.07.029","article-title":"Perioperative adverse events attributed to \u03b12-adrenoceptor agonists in patients not at risk of cardiovascular events: Systematic review and meta-analysis","volume":"123","author":"Demiri","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2021.05.008_bib0041","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/15563650.2018.1450986","article-title":"Naloxone reversal of clonidine toxicity: Dose, dose, dose","volume":"56","author":"Seger","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1053\/j.jvca.2021.05.008_bib0042","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/ALN.0000000000003725","article-title":"Balanced opioid-free anesthesia with dexmedetomidine versus balanced anesthesia with remifentanil for major or intermediate noncardiac surgery","volume":"134","author":"Beloeil","year":"2021","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2021.05.008_bib0043","first-page":"552","article-title":"Adverse reactions of amiodarone","volume":"16","author":"Colunga Biancatelli","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0044","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1213\/ANE.0000000000004474","article-title":"Atrial fibrillation: Current evidence and management strategies during the perioperative period","volume":"130","author":"Karamchandani","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.05.008_bib0045","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/STROKEAHA.118.023921","article-title":"Perioperative\/postoperative atrial fibrillation and risk of subsequent stroke and\/or mortality","volume":"50","author":"Lin","year":"2019","journal-title":"Stroke"},{"key":"10.1053\/j.jvca.2021.05.008_bib0046","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archinte.166.9.1016","article-title":"Corticosteroids and the risk of atrial fibrillation","volume":"166","author":"van der Hooft","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.jvca.2021.05.008_bib0047","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/archinternmed.2009.297","article-title":"Glucocorticoid use and risk of atrial fibrillation or flutter: A population-based, case-control study","volume":"169","author":"Christiansen","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.jvca.2021.05.008_bib0048","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijcard.2014.12.094","article-title":"Dexamethasone for the prevention of postoperative atrial fibrillation","volume":"182","author":"van Osch","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0049","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.jvca.2005.10.014","article-title":"Effect of dexamethasone on atrial fibrillation after cardiac surgery: Prospective, randomized, double-blind, placebo-controlled trial","volume":"21","author":"Yared","year":"2007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.05.008_bib0050","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/jama.297.14.1562","article-title":"Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: A randomized controlled trial","volume":"297","author":"Halonen","year":"2007","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2021.05.008_bib0051","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezz325","article-title":"The efficacy and safety of prophylactic corticosteroids for the prevention of adverse outcomes in patients undergoing heart surgery using cardiopulmonary bypass: A systematic review and meta-analysis of randomized controlled trials","volume":"57","author":"Ng","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2021.05.008_bib0052","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1161\/CIRCULATIONAHA.108.848218","article-title":"Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: A dose-response meta-analysis","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.008_bib0053","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180462","article-title":"Steroids prevent early recurrence of atrial fibrillation following catheter ablation: A systematic review and meta-analysis","volume":"38","author":"Lei","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1053\/j.jvca.2021.05.008_bib0054","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.4022\/jafib.1604","article-title":"Use of oral steroid and its effects on atrial fibrillation recurrence and inflammatory cytokines post ablation \u2013 The Steroid AF Study","volume":"9","author":"Iskandar","year":"2017","journal-title":"J Atr Fibrillation"},{"key":"10.1053\/j.jvca.2021.05.008_bib0055","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehr421","article-title":"Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib","volume":"33","author":"B\u00e4ck","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.05.008_bib0056","first-page":"362","article-title":"Diclofenac use and cardiovascular risks: Series of nationwide cohort studies","author":"Schmidt","year":"2018","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1053\/j.jvca.2021.05.008_bib0057","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/archinternmed.2010.305","article-title":"Long-term use of anti-inflammatory drugs and risk of atrial fibrillation","volume":"170","author":"De Caterina","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.jvca.2021.05.008_bib0058","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004059","article-title":"Non-steroidal anti-inflammatory drugs and the risk of atrial fibrillation: A population-based follow-up study","volume":"4","author":"Krijthe","year":"2014","journal-title":"BMJ Open"},{"key":"10.1053\/j.jvca.2021.05.008_bib0059","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.amjcard.2014.08.015","article-title":"Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of atrial fibrillation","volume":"114","author":"Liu","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/anec.12097","article-title":"Celecoxib-induced change in atrial electrophysiologic substrate in arthritis patients","volume":"19","author":"Pizzuto","year":"2014","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0061","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/eurheartj\/ehv505","article-title":"Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: Review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology","volume":"37","author":"Schmidt","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.05.008_bib0062","doi-asserted-by":"crossref","first-page":"e3102","DOI":"10.1097\/MD.0000000000003102","article-title":"Atrial fibrillation is associated with morphine treatment in female breast cancer patients: A retrospective population-based time-dependent cohort study","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.jvca.2021.05.008_bib0063","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jamainternmed.2015.1045","article-title":"Association between opioid use and atrial fibrillation: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study","volume":"175","author":"Qureshi","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.jvca.2021.05.008_bib0064","first-page":"174","article-title":"Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease","volume":"52","author":"Buff","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1053\/j.jvca.2021.05.008_bib0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0971-9784.51361","article-title":"A comparison of the effects of desflurane, sevoflurane and propofol on QT, QTc, and P dispersion on ECG","volume":"12","author":"Kazanci","year":"2009","journal-title":"Ann Card Anaesth"},{"key":"10.1053\/j.jvca.2021.05.008_bib0066","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00000539-200001000-00006","article-title":"Sevoflurane, but not propofol, significantly prolongs the Q-T interval","volume":"90","author":"Kleinsasser","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.05.008_bib0067","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.genhosppsych.2020.08.008","article-title":"Intravenous haloperidol: A systematic review of side effects and recommendations for clinical use","volume":"67","author":"Beach","year":"2020","journal-title":"Gen Hosp Psychiatr"},{"key":"10.1053\/j.jvca.2021.05.008_bib0068","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mayocp.2013.10.008","article-title":"Perioperative doses of ondansetron or dolasetron do not lengthen the QT interval","volume":"89","author":"Obal","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.jvca.2021.05.008_bib0069","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijcard.2017.01.011","article-title":"The possible role of propofol in drug-induced torsades de pointes: A real-world single-center analysis","volume":"232","author":"Abrich","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0070","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1038\/s41598-020-69193-7","article-title":"Propofol abolishes torsade de pointes in different models of acquired long QT syndrome","volume":"10","author":"Ellermann","year":"2020","journal-title":"Sci Rep"},{"key":"10.1053\/j.jvca.2021.05.008_bib0071","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1213\/ane.0b013e3181609424","article-title":"The prophylactic effect of haloperidol plus dexamethasone on postoperative nausea and vomiting in patients undergoing laparoscopically assisted vaginal hysterectomy","volume":"106","author":"Chu","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.05.008_bib0072","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1213\/ane.0b013e31816091f0","article-title":"Haloperidol plus ondansetron versus ondansetron alone for prophylaxis of postoperative nausea and vomiting","volume":"106","author":"Grecu","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.05.008_bib0073","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1213\/ane.0b013e3181609022","article-title":"Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting","volume":"106","author":"Rosow","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.05.008_bib0074","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF03022656","article-title":"Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting","volume":"54","author":"Lee","year":"2007","journal-title":"Can J Anaesth"},{"key":"10.1053\/j.jvca.2021.05.008_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2019.09.017","article-title":"Efficacy and safety of haloperidol for delirium prevention in adult patients: An updated meta-analysis with trial sequential analysis of randomized controlled trials","volume":"61","author":"Chen","year":"2020","journal-title":"J Clin Anesth"},{"key":"10.1053\/j.jvca.2021.05.008_bib0076","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jcrc.2019.01.009","article-title":"Haloperidol for the management of delirium in adult intensive care unit patients: A systematic review and meta-analysis of randomized controlled trials","volume":"50","author":"Zayed","year":"2019","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2021.05.008_bib0077","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1478951520000231","article-title":"QTc prolongation after haloperidol administration in critically ill patients post cardiovascular surgery: A cohort study and review of the literature","volume":"18","author":"Burbuqe","year":"2020","journal-title":"Palliat Support Care"},{"key":"10.1053\/j.jvca.2021.05.008_bib0078","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ageing\/afaa066","article-title":"Should we still monitor QTc duration in frail older patients on low-dose haloperidol? A prospective observational cohort study","volume":"49","author":"Castro","year":"2020","journal-title":"Age Ageing"},{"key":"10.1053\/j.jvca.2021.05.008_bib0079","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/ccr3.2251","article-title":"Ondansetron induced torsades de pointes","volume":"7","author":"Patel","year":"2019","journal-title":"Clin Case Rep"},{"key":"10.1053\/j.jvca.2021.05.008_bib0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.14503\/THIJ-16-6040","article-title":"Torsades de pointes after ondansetron infusion in 2 patients","volume":"44","author":"Lee","year":"2017","journal-title":"Tex Heart Inst J"},{"key":"10.1053\/j.jvca.2021.05.008_bib0081","first-page":"53","article-title":"Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: A prospective, observational study","volume":"3","author":"Hafermann","year":"2011","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1053\/j.jvca.2021.05.008_bib0082","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/acem.12836","article-title":"Intravenous ondansetron and the QT interval in adult emergency department patients: An observational study","volume":"23","author":"Moffett","year":"2016","journal-title":"Acad Emerg Med"},{"key":"10.1053\/j.jvca.2021.05.008_bib0083","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000542-200506000-00006","article-title":"Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron","volume":"102","author":"Charbit","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2021.05.008_bib0084","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ihj.2017.05.024","article-title":"Incidence of drug-induced torsades de pointes with intravenous amiodarone","volume":"69","author":"Shenthar","year":"2017","journal-title":"Indian Heart J"},{"key":"10.1053\/j.jvca.2021.05.008_bib0085","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","article-title":"Rate control versus rhythm control for atrial fibrillation after cardiac surgery","volume":"374","author":"Gillinov","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2021.05.008_bib0086","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/ALN.0b013e3181c61b28","article-title":"Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery","volume":"112","author":"Beaulieu","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2021.05.008_bib0087","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.hrthm.2009.07.002","article-title":"Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)","volume":"6","author":"Postema","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.jvca.2021.05.008_bib0088","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/ALN.0000000000003030","article-title":"Electrocardiographic effects of propofol versus etomidate in patients with Brugada syndrome","volume":"132","author":"Flamee","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2021.05.008_bib0089","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/pace.13342","article-title":"Propofol for implantable cardioverter defibrillator implantation in patients with Brugada syndrome","volume":"41","author":"Kwon","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jclinane.2016.09.031","article-title":"Anesthesia and Brugada syndrome: A 12-year case series","volume":"36","author":"Duque","year":"2017","journal-title":"J Clin Anesth"},{"key":"10.1053\/j.jvca.2021.05.008_bib0091","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/pace.12246","article-title":"Safe single-dose administration of propofol in patients with established Brugada syndrome: A retrospective database analysis","volume":"36","author":"Flamee","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1053\/j.jvca.2021.05.008_bib0092","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/LRA.S154512","article-title":"Local anesthetic systemic toxicity: Current perspectives","volume":"11","author":"El-Boghdadly","year":"2018","journal-title":"Local Reg Anesth"},{"issue":"1","key":"10.1053\/j.jvca.2021.05.008_bib0093","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1540-8167.2010.01766.x","article-title":"Transient ST elevation after ketamine intoxication: a new cause of acquired brugada ECG pattern","volume":"22","author":"Rollin","year":"2011","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021003815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021003815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:56:54Z","timestamp":1760947014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077021003815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1053077021003815"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2021.05.008","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative Implications of the 2020 American Heart Association Scientific Statement on Drug-Induced Arrhythmias\u2014A Focused Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2021.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}